Portfolio company Disc Medicine presents positive initial data from Phase 2 BEACON trial at EHA
Portfolio company Disc Medicine presents positive initial data from Phase 2 BEACON trial at EHA
Stay updated with breaking news from John Quisel. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Portfolio company Disc Medicine presents positive initial data from Phase 2 BEACON trial at EHA
Disc Medicine, Inc. , a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic... | May 15, 2023
Disc Medicine, Inc. , a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic... | March 31, 2023
Investegate announcements from Arix Bioscience PLC, Portfolio company Disc Medicine announces $62.5 million financing
Investegate announcements from Arix Bioscience PLC, Portfolio Company Disc Medicine Completes Merger with Gemini Therapeutics